Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the approval of a GLP-1 pill for weight ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to Regulations ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

It’s like a switch that goes on and you’re instantly starving.” Tanya Hall’s words capture a reality many face when they stop ...

The new drug, simply called the Wegovy pill, marks a turning point in the modern weight-loss revolution. Until now, every ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

Danish pharmaceutical manufacturer Novo Nordisk on Dec. 22 announced that the U.S. Food and Drug Administration (FDA) has ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk ...